Business Context and Reporting Period
This Form 6-K filing by Fresenius Medical Care AG & Co. KGaA covers the month of January 2017. The registrant is a German partnership limited by shares with principal executive offices in Bad Homburg, Germany. The filing serves to distribute an Investor News Release issued on January 31, 2017, to U.S. investors.
Financial Metrics
The provided filing text contains only the cover page, signature block, and exhibit listing for the Form 6-K. It does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The actual financial data is contained within the referenced Exhibit 99.1 (Investor News Release), which is not included in the input text.
Material Changes
The filing text does not disclose any material changes versus prior periods. No comparative financial data or operational updates are present in the provided content.
Guidance, Outlook, and Risks
The text does not contain management commentary, guidance, outlook, risk factors, or details on contingencies and unusual items. These elements are presumed to be within the attached Investor News Release (Exhibit 99.1), which is not part of the input data.
Key Facts for Investor Verification
- Verify the contents of Exhibit 99.1 (Investor News Release issued January 31, 2017) for actual financial results and strategic updates.
- Confirm the filing is signed by Rice Powell (CEO) and Michael Brosnan (CFO) on behalf of the General Partner.
- Note that the registrant files annual reports under Form 20-F.
- Check if the filing is being furnished pursuant to Rule 12g3-2(b) (marked "No" in this document).